Progressive cognitive disturbances in a 17-year-old boy Background;Progressieve cognitieve stoornissen bij een 17-jarige

Nederlands Tijdschrift voor Geneeskunde

Volumn 159, Issue 12, 2015, Pages

  Hepp, Dagmar H ^a   Van Dijk, Karin ^b   Stam, Cornelis J ^b   Van Oosten, Bob W ^a   Foncke, Elisabeth M J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Afd Medische Microbiologie en Infectiepreventie ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; COGNITIVE DEFECT; DEATH; ELECTROENCEPHALOGRAPHY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MALE; MEASLES; RELIGION; SUBACUTE SCLEROSING PANENCEPHALITIS; COGNITION DISORDERS; COMPLICATION; FATALITY; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING;

MEASLES VACCINE;

ADOLESCENT; COGNITION DISORDERS; FATAL OUTCOME; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEASLES; MEASLES VACCINE; NETHERLANDS; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 84930412192     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Campbell H, Andrews N, Brown KE, Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol. 2007;36:1334-48.
2. Vos MJ, Zaaijer HL, Barkhof F, Galama JMD, Uitdehaag BMJ. Een 36-jarige patiënte met subacute scleroserende panencefalitis (SSPE). Ned Tijdschr Neurol. 2001;5:371-6.
3. Radermecker J, Macken J. Aspects électroencéphalographiques et cliniques de la leucoencéphalite sclérosante subaiguë; leur valeur au point de vue du diagnostic différentiel avec d'autres encéphalopathies subaiguës et certaines tumeurs de l'enfance. [Clinical and electroencephalographic aspects of subacute sclerosing leukoencephalitis; differential diagnosis from other subacute encephalopathies and certain tumors in children]. Rev Neurol (Paris). 1951;85:341-70.
4. Visudtibhan A, Mehta PD, Kulczycki J, Coyle PK, Thormar H. Intrathecal production of measles-specific IgA in subacute sclerosing panencephalitis. Acta Neurol Scand. 1997;96:97-100.
5. Garg RK. Subacute sclerosing panencephalitis. J Neurol. 2008;255:1861-71.
6. Rijksinstituut voor Volksgezondheid en Milieu. LCI-richtlijn Mazelen (morbilli). www.rivm.nl/Documenten-en-publicaties/Professioneel-Praktisch/Richtlijnen/Infectieziekten/LCI-richtlijnen/LCI-richtlijn- Mazelen-morbilli, geraadpleegd op 1 oktober 2014.
7. Beersma MFC, Kapsenberg JG, Renier WO, Galama JMD, van Druten JAM, Lucas CJ. Subacute scleroserende panencefalitis in Nederland (1976-1986). Ned Tijdschr Geneeskd. 1988;132:1194-9.
8. Schonberger K, Ludwig MS, Wildner M, Weissbrich B. Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation. PLoS ONE. 2013;8:e68909.
9. Risk WS, Haddad FS. The variable natural history of subacute sclerosing panencephalitis: a study of 118 cases from the Middle East. Arch Neurol. 1979;36:610-4.
10. Ravikumar S, Crawford JR. Role of Carbamazepine in the symptomatic treatment of subacute sclerosing panencephalitis: a case report and review of the literature, Case Reports in Neurological Medicine. 2013;1-5.